Stomach cancer trial combines chemo with Bacteria-Fighting treatment
NCT ID NCT06510010
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study is for people with a type of stomach cancer that is H. pylori-positive and can be removed with surgery. It compares standard chemotherapy before and after surgery to the same chemotherapy plus treatment to eliminate H. pylori bacteria. The goal is to see if adding the bacteria treatment helps shrink the tumor more before surgery. About 180 adults will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY EFFECT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Sixth Affiliated Hospital，Sun Yat-sen University
RECRUITINGGuangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict chemo brain before it happens?
- Virtual reality vs. relaxing videos: a new weapon against chemo side effects?
- Biopsy DNA clues could spare esophageal cancer patients from futile chemo
- Hypnosis may ease Chemotherapy's toll on breast cancer patients
- Exercise may boost heart fitness in hodgkin survivors
- Could a liver-protecting herb boost leukemia chemo? new trial aims to find out.